An Alternative Approach to Assess Exchangeability of a Test Treatment and the Standard Treatment with Normally Distributed ResponseFootnote∗

∗This paper does not represent the official position of U.S. Food and Drug Administration.

REFERENCES

• Chow , S. C. , Liu , J. P. ( 2000 ). Design and Analysis of Bioavailability and Bioequivalence Studies . New York : Marcel Dekker, Inc .
   Google Scholar
• Esinhart , J. D. , Chinchilli , V. M. ( 1994 ). Extension to the use of tolerance interval for the assessment of individual bioequivalence . J. Biopharm. Stat. 4 : 39 – 52 .
   PubMedGoogle Scholar
• Faulkenberry , G. D. , Daley , J. C. ( 1970 ). Sample size for tolerance limits on a normal distribution . Technometrics 12 : 813 – 821 .
   Web of Science ®Google Scholar
• Johnson , N. L. , Kotz , S. , Balakrishnan , N. ( 1995 ). Continuous Univariate Distributions . Vol. 2 . New York : John Wiley & Sons .
   Google Scholar
• Liu , J. P. , Chow , S. C. ( 1997 ). A two one-sided tests procedure for assessing individual bioequivalence . J. Biopharm. Stat. 7 : 49 – 61 .
   PubMedGoogle Scholar
• Tsong , Y. , Shen , M. , Shah , V. P. ( 2004 ). Three-stage sequential statistical dissolution testing rules . J. Biopharm. Stat. 14 : 757 – 779 .
   PubMedGoogle Scholar
• Wald , A. , Wolfowitz , J. ( 1946 ). Tolerance limits for a normal distribution . Ann. Math. Stat. 19 : 208 – 215 .
   Google Scholar
• ∗This paper does not represent the official position of U.S. Food and Drug Administration.
   Google Scholar